TD Cowen maintains Buy on Universal Health Services, cuts target to $197
TD Cowen analyst Ryan Langston maintained a Buy rating on Universal Health Services but reduced the price target to $197 from $230. The revision adjusts the valuation outlook while retaining a positive stance on the stock.
*this image is generated using AI for illustrative purposes only.
TD Cowen analyst Ryan Langston has maintained a Buy rating on Universal Health Services (NYSE: UHS) while adjusting the valuation outlook. The firm lowered the price target to $197, down from the previous $230. The revised target reflects updated projections for the healthcare services provider.
Rating and Target Details
The decision to keep the Buy rating suggests confidence in the company's fundamental performance despite the lower price objective. Universal Health Services operates behavioral health and acute care hospitals, sectors that remain critical to the healthcare infrastructure.
| Metric | Value |
|---|---|
| Rating | Buy |
| Previous Price Target | $230 |
| New Price Target | $197 |
The adjustment in the price target indicates a recalibration of expected returns rather than a shift in the fundamental investment thesis. Shareholders should note the specific revision to the target price as the primary material change in this update.
What specific factors led to the downward revision of the price target despite the maintained Buy rating?
How might Universal Health Services' performance in behavioral health and acute care sectors influence future earnings?
What market trends or regulatory changes could impact UHS's growth trajectory in the near term?
20
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
